Affiliation:
1. Office of Surveillance and Epidemiology; Division of Pharmacovigilance; FDA Center for Drug Evaluation and Research; Silver Spring MD USA
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Reference8 articles.
1. Letter: eluxadoline-associated pancreatitis-myth or reality?;Garcia-Gonzalez;Aliment Pharmacol Ther,2018
2. Postmarketing cases of eluxadoline-associated pancreatitis in patients with or without a gallbladder;Harinstein;Aliment Pharmacol Ther,2018
3. Eluxadoline for irritable bowel syndrome with diarrhea;Lembo;NEJM,2016
4. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus;Bank;Gut,2013
5. U.S. Food and Drug Administration 2005 Guidance for industry: Good pharmacovigilance practices and pharmacoepidemiologic assessment https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm071696.pdf